Zobrazeno 1 - 10
of 85
pro vyhledávání: '"A. M. Staiger"'
Autor:
D. Noerenberg, F. Briest, C. Hennch, K. Yoshida, J. Nimo, R. Hablesreiter, Y. Takeuchi, D. Sasca, H. Ueno, L. Mansouri, Y. Inoue, L. Wiegand, A. M. Staiger, B. Casadei, M. Ziepert, F. Asmar, P. Korkolopoulou, M. Kirchner, P. Mertins, J. Weiner, E. Toth, T. Weber, A. Warth, T. Schneider, R.-M. Amini, W. Klapper, M. Hummel, V. Poeschel, G. Kanellis, A. Rosenwald, G. Held, E. Campo, K. Stamatopoulos, I. Anagnostopoulos, L. Bullinger, N. Goldschmidt, P. L. Zinzani, C. Bödor, R. Rosenquist, T. P. Vassilakopoulos, G. Ott, S. Ogawa, F. Damm
Publikováno v:
HemaSphere, Vol 6, Pp 2-3 (2022)
Externí odkaz:
https://doaj.org/article/d54a8cd5040e4d8d8fba3b1b3fbe8223
Autor:
Fabian Frontzek, Annette M. Staiger, Myroslav Zapukhlyak, Wendan Xu, Irina Bonzheim, Vanessa Borgmann, Philip Sander, Maria Joao Baptista, Jan-Niklas Heming, Philipp Berning, Ramona Wullenkord, Tabea Erdmann, Mathias Lutz, Pia Veratti, Sophia Ehrenfeld, Kirsty Wienand, Heike Horn, John R. Goodlad, Matthew R. Wilson, Ioannis Anagnostopoulos, Mario Lamping, Eva Gonzalez-Barca, Fina Climent, Antonio Salar, Josep Castellvi, Pau Abrisqueta, Javier Menarguez, Teresa Aldamiz, Julia Richter, Wolfram Klapper, Alexandar Tzankov, Stefan Dirnhofer, Andreas Rosenwald, José Luis Mate, Gustavo Tapia, Peter Lenz, Cornelius Miething, Wolfgang Hartmann, Björn Chapuy, Falko Fend, German Ott, José-Tomas Navarro, Michael Grau, Georg Lenz
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-14 (2021)
Plasmablastic lymphoma (PBL) is an aggressive lymphoma subtype characterized by poor prognosis but the molecular knowledge of the disease is limited. Here, the authors perform whole exome sequencing and copy number determination of primary samples hi
Externí odkaz:
https://doaj.org/article/6d054d5ed82e4409b9428afb7baa476b
Autor:
Katrin S. Kurz, Michaela Ott, Sabrina Kalmbach, Sophia Steinlein, Claudia Kalla, Heike Horn, German Ott, Annette M. Staiger
Publikováno v:
Cancers, Vol 15, Iss 8, p 2285 (2023)
The family/class of the large B-cell lymphomas (LBCL) in the 5th edition of the World Health Organization (WHO) classification of haematolymphoid tumors (WHO-HAEM5) features only a few major changes as compared to the 4th edition. In most entities, t
Externí odkaz:
https://doaj.org/article/37e8cf8e091e479bbfc40ff8e424bc23
Publikováno v:
Cancers, Vol 15, Iss 3, p 785 (2023)
The conceptual description of Follicular lymphoma (FL) in the 5th edition of the World Health Organization (WHO) classification of haematolymphoid tumors (WHO-HAEM5) has undergone significant revision. The vast majority of FL (85%) with a follicular
Externí odkaz:
https://doaj.org/article/911b8a8c58154a97ab892fc284cf44ca
Autor:
Noelia Díaz, Kai Kruse, Tabea Erdmann, Annette M. Staiger, German Ott, Georg Lenz, Juan M. Vaquerizas
Publikováno v:
Nature Communications, Vol 9, Iss 1, Pp 1-13 (2018)
Chromatin conformation studies are limited by the large amounts of starting material required to perform current protocols. Here the authors present Low-C, a Hi-C method for low amounts of input material and produce Low-C maps from primary B-cells of
Externí odkaz:
https://doaj.org/article/c203c0b2003646cea3a7eb3e347a72fc
Autor:
Michael Mentz, William Keay, Carolin Dorothea Strobl, Martina Antoniolli, Louisa Adolph, Michael Heide, Axel Lechner, Sarah Haebe, Elisa Osterode, Robert Kridel, Christoph Ziegenhain, Lucas Esteban Wange, Johannes Adrian Hildebrand, Tanaya Shree, Elisabeth Silkenstedt, Annette M. Staiger, German Ott, Heike Horn, Monika Szczepanowski, Julia Richter, Ronald Levy, Andreas Rosenwald, Wolfgang Enard, Ursula Zimber-Strobl, Michael von Bergwelt-Baildon, Wolfgang Hiddemann, Wolfram Klapper, Marc Schmidt-Supprian, Martina Rudelius, Deepak Bararia, Verena Passerini, Oliver Weigert
Publikováno v:
Leukemia 36, 2281–2292 (2022)
The variable clinical course of follicular lymphoma (FL) is determined by the molecular heterogeneity of tumor cells and complex interactions within the tumor microenvironment (TME). IL-4 producing follicular helper T cells (TFH) are critical compone
Autor:
Gerhard Held, Viola Poeschel, Lorenz Trümper, Julia Richter, Karoline Koch, Andreas Rosenwald, Marita Ziepert, Annette M. Staiger, Sarah Reinke, W. Klapper, Rex Au-Yeung, Rainer Spang, Markus Loeffler, Giorgio Alberto Croci, Ilske Oschlies, Bettina Altmann, German Ott
Publikováno v:
Annals of Oncology. 32:1400-1409
Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous disease with respect to outcome. Features of the tumor microenvironment (TME) are associated with prognosis when assessed by gene expression profiling. However, it is uncertain whether assessme
Autor:
German Ott, Sören Franzenburg, Ulrike Paul, Wolfram Klapper, Ilske Oschlies, Jasmin Finger, Christian W. Kohler, Rainer Spang, Ulf Michgehl, Reiner Siebert, Andreas Rosenwald, Julia Richter, Birgit Burkhardt, Katrin S. Kurz, Annette M. Staiger, Katharina John
Publikováno v:
British Journal of Haematology. 196:681-689
Sporadic Burkitt lymphoma (BL) is the most frequent tumour of children and adolescents but a rare subtype of lymphomas in adults. To date most molecular data have been obtained from lymphomas arising in the young. Recently, Epstein-Barr virus (EBV) p
Autor:
Fabian Frontzek, Annette M. Staiger, Ramona Wullenkord, Michael Grau, Myroslav Zapukhlyak, Katrin S. Kurz, Heike Horn, Tabea Erdmann, Falko Fend, Julia Richter, Wolfram Klapper, Peter Lenz, Stephan Hailfinger, Anna Tasidou, Marcel Trautmann, Wolfgang Hartmann, Andreas Rosenwald, Leticia Quintanilla-Martinez, German Ott, Ioannis Anagnostopoulos, Georg Lenz
Publikováno v:
Leukemia.
Epstein-Barr virus (EBV) associated diffuse large B-cell lymphoma (DLBCL) represents a rare aggressive B-cell lymphoma subtype characterized by an adverse clinical outcome. EBV infection of lymphoma cells has been associated with different lymphoma s
Autor:
Martin Bentz, Martin Dreyling, Annette M. Staiger, Andreas Rosenwald, Marita Ziepert, Lorenz Truemper, Bernd Metzner, Mathias Haenel, Norbert Schmitz, Markus Loeffler, Gerhard Held, Bertram Glass, Bettina Altmann, Heike Horn, Georg Lenz, German Ott, Maike Nickelsen, Peter Borchmann, Fabian Frontzek, Frank Kroschinsky, Andreas Viardot
Publikováno v:
The Lancet Haematology. 8:e267-e277
Summary Background R-MegaCHOEP was the first phase 3 study comparing high-dose chemotherapy plus rituximab followed by autologous haematopoietic stem-cell transplantation (HSCT) with conventional chemotherapy plus rituximab in first-line therapy for